Technical Resources

What can researchers do?

Researchers can use scientific evidence to influence policy by getting it into the hands of decision makers. In order to inform health policy, decision makers need data on disease burden, intervention impact, safety and cost effectiveness. To support these efforts, the ROTA Council provides recommendations for key stakeholders, reports and guidelines from scientific bodies, and speaker presentations from technical symposiums.

Click on a category below to reveal resources.

Event Presentations

 

International Rotavirus Symposium

The PDF versions of speaker presentations are available for download on the Sabin Vaccine Institute website.

Download: 12th (Melbourne, 2016)11th (Delhi 2014) | 10th (Bangkok 2012)

Recommendations and Guidelines

 

ROTA Council Recommendations

By ROTA Council, 2015
To accelerate the introduction of life-saving, health-improving rotavirus vaccines, the ROTA Council recommends key stakeholders – in countries where these vaccines have not yet been introduced – undertake specific actions.

Download: Slide Deck PDF | Slide Deck PPT

 

Rotavirus Vaccination and Intussusception

By ROTA Council and partners, 2015
Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries.

Download

 

Rotavirus Vaccine Recommendations

By Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC)
The ACIP provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States.

Download

WHO Publications

 

Updated Position Paper on Rotavirus Vaccines

2013
This paper summarizes recent developments in the field, in particular the potential of rotavirus vaccines to further reduce mortality by employing more flexible immunization schedules. All WHO recommendations appear at the end of this paper and reflect those offered by SAGE. This version replaces the 2009 and 2007 papers.

Download | Past Papers: 2009, 2007

 

Weekly Epidemiological Record: Safety Profile on ROTAVAC®

2014
The Global Advisory Committee on Vaccine Safety (GACVS) provides independent, scientifically rigorous advice on vaccine safety issues of potential global importance. This document describes the safety profile of the live attenuated rotavirus vaccine Rotavac®.

Download

 

Weekly Epidemiological Record: Recommendation on Rotavirus Immunization Schedules

2012
SAGE reviewed new evidence that afforded an opportunity to avert additional deaths from rotavirus disease. SAGE continues to recommend that the first dose of rotavirus vaccine be administered along with DTP, as soon as possible after 6 weeks of age as this maximizes disease protection.

Download

 

Generic protocol for monitoring impact of rotavirus vaccination on gastroenteritis disease burden and viral strains

2008
This generic protocol outlines a uniform approach to monitoring the impact of rotavirus vaccines that can be modified by countries to meet their specific needs. The primary overall objectives of this protocol are to determine vaccine impact, determine, vaccine effectiveness and to monitor for possible changing strain patterns in vaccinated populations.

Download

 

Guidelines for estimating the economic burden of diarrhoeal disease, with focus on assessing the costs of rotavirus diarrhoea

2005
The objective of these guidelines is to present a method for determining the costs associated with diarrheal disease in children under five years of age. Methods for estimating the costs from the viewpoint of the health sector and for society as a whole are explained.

Download

Reports

 

Pneumonia and Diarrhea Progress Report

By International Vaccine Access Center 
The annual report details the 15 countries with the greatest burden of under-5 pneumonia and diarrhea deaths, and their progress in implementing high-impact interventions outlined in the Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea.

Download: 2016 | 2015 | 2014

Gap Analysis of Rotavirus Vaccine Impact Evaluations in Settings of Routine Use

By International Vaccine Access Center 
This report describes the global state of rotavirus vaccine use and the availability of RVV impact evidence as of November 3, 2016 in countries routinely using rotavirus vaccines.

Download: 2017

Digital Platforms

 

Vaccine Information and Epidemiology Window hub

By International Vaccine Access Center 
VIEW-hub—an online, interactive vaccine information tool—allows users to instantly visualize data about vaccine introductions, product usage, dosing schedules, access, coverage, and more for a number of vaccines. Custom queries and maps, exportable data and graphics, and a map gallery are just some of the interactive features users can access. IVAC publishes quarterly reports on Global Vaccine Introduction and Implementation from VIEW-hub.

Download the Latest Reports | Access VIEW-hub

 

Vaccine Product, Price and Procurement Database

By WHO
The V3P database is a web-based platform that countries can use to collect, collate, and share vaccine price and procurement information. As much as possible, the V3P database attempts to present data that is comparable between countries. The database includes publicly accessible information from WHO, UNICEF and the PAHO revolving fund as well as information from participating countries.

Access V3P

 

The Vaccine Resource Library

By PATH
The library gathers top immunization resources in a single website and offers high-quality, scientifically accurate materials on specific diseases and topics in immunization addressed by PATH’s work. The database can be filtered to specific parameters.

Access the Library | Filter by Rotavirus

 

Rotavirus Resources

By WHO
The webpage provides a listing of technical resources organized by policy and decision making, implementation, and monitoring and surveillance.

Access the Resources